Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pan Du

Showing results (151-160 of 166) with videos related to

Pageof 17
Sort By:
European Urology|September 8, 2021
Avelumab Combined with Stereotactic Ablative Body Radiotherapy in Metastatic Castration-resistant Prostate Cancer: The Phase 2 ICE-PAC Clinical TrialEdmond M Kwan, Lavinia Spain, Angelyn Anton, et al.
Expert Review of Vaccines|September 1, 2022
Batch-to-batch consistency trial of an adenovirus type-5 vector-based COVID-19 vaccine in adults aged 18 years and aboveZhuo-Pei Li, Yun-Feng Shi, Li-Hua Hou, et al.
European Urology|October 6, 2023
Novel Use of Circulating Tumor DNA to Identify Muscle-invasive and Non-organ-confined Upper Tract Urothelial CarcinomaHeather L Huelster, Billie Gould, Elizabeth A Schiftan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2021
Correction: A Virus-infected, Reprogrammed Somatic Cell-derived Tumor Cell (VIReST) Vaccination Regime can Prevent Initiation and Progression of Pancreatic CancerShuangshuang Lu, Zhe Zhang, Pan Du, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 27, 2019
A Virus-Infected, Reprogrammed Somatic Cell-Derived Tumor Cell (VIReST) Vaccination Regime Can Prevent Initiation and Progression of Pancreatic CancerShuangshuang Lu, Zhe Zhang, Pan Du, et al.
Nature Communications|August 26, 2022
The CCTG PA.7 phase II trial of gemcitabine and nab-paclitaxel with or without durvalumab and tremelimumab as initial therapy in metastatic pancreatic ductal adenocarcinomaDaniel J Renouf, Jonathan M Loree, Jennifer J Knox, et al.
Nature Communications|March 7, 2026
DNA Repair gene alterations and efficacy from gemcitabine and nab-paclitaxel with/without durvalumab and tremelimumab in metastatic pancreatic ductal adenocarcinomaDaniel J Renouf, James T Topham, Jonathan M Loree, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 9, 2026
Urinary Biomarkers Objectively Measure Minimal Residual Disease in Non-Muscle-Invasive Bladder CancerAndrew B Katims, Charlie White, Syed Muneeb Alam, et al.
Plos Genetics|September 18, 2018
Disrupted structure and aberrant function of CHIP mediates the loss of motor and cognitive function in preclinical models of SCAR16Chang-He Shi, Carrie Rubel, Sarah E Soss, et al.
The Lancet Regional Health. Western Pacific|June 26, 2023
Immunogenicity and safety of heterologous immunisation with Ad5-nCOV in healthy adults aged 60 years and older primed with an inactivated SARS-CoV-2 vaccine (CoronaVac): a phase 4, randomised, observer-blind, non-inferiority trialPeng-Fei Jin, Xi-Ling Guo, Jin-Bo Gou, et al.
Pageof 17

Showing results (151-160 of 166) with videos related to

Sort By:
Pageof 17
European Urology|September 8, 2021
Avelumab Combined with Stereotactic Ablative Body Radiotherapy in Metastatic Castration-resistant Prostate Cancer: The Phase 2 ICE-PAC Clinical TrialEdmond M Kwan, Lavinia Spain, Angelyn Anton, et al.
Expert Review of Vaccines|September 1, 2022
Batch-to-batch consistency trial of an adenovirus type-5 vector-based COVID-19 vaccine in adults aged 18 years and aboveZhuo-Pei Li, Yun-Feng Shi, Li-Hua Hou, et al.
European Urology|October 6, 2023
Novel Use of Circulating Tumor DNA to Identify Muscle-invasive and Non-organ-confined Upper Tract Urothelial CarcinomaHeather L Huelster, Billie Gould, Elizabeth A Schiftan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2021
Correction: A Virus-infected, Reprogrammed Somatic Cell-derived Tumor Cell (VIReST) Vaccination Regime can Prevent Initiation and Progression of Pancreatic CancerShuangshuang Lu, Zhe Zhang, Pan Du, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 27, 2019
A Virus-Infected, Reprogrammed Somatic Cell-Derived Tumor Cell (VIReST) Vaccination Regime Can Prevent Initiation and Progression of Pancreatic CancerShuangshuang Lu, Zhe Zhang, Pan Du, et al.
Nature Communications|August 26, 2022
The CCTG PA.7 phase II trial of gemcitabine and nab-paclitaxel with or without durvalumab and tremelimumab as initial therapy in metastatic pancreatic ductal adenocarcinomaDaniel J Renouf, Jonathan M Loree, Jennifer J Knox, et al.
Nature Communications|March 7, 2026
DNA Repair gene alterations and efficacy from gemcitabine and nab-paclitaxel with/without durvalumab and tremelimumab in metastatic pancreatic ductal adenocarcinomaDaniel J Renouf, James T Topham, Jonathan M Loree, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 9, 2026
Urinary Biomarkers Objectively Measure Minimal Residual Disease in Non-Muscle-Invasive Bladder CancerAndrew B Katims, Charlie White, Syed Muneeb Alam, et al.
Plos Genetics|September 18, 2018
Disrupted structure and aberrant function of CHIP mediates the loss of motor and cognitive function in preclinical models of SCAR16Chang-He Shi, Carrie Rubel, Sarah E Soss, et al.
The Lancet Regional Health. Western Pacific|June 26, 2023
Immunogenicity and safety of heterologous immunisation with Ad5-nCOV in healthy adults aged 60 years and older primed with an inactivated SARS-CoV-2 vaccine (CoronaVac): a phase 4, randomised, observer-blind, non-inferiority trialPeng-Fei Jin, Xi-Ling Guo, Jin-Bo Gou, et al.
Pageof 17